In order to further confirm STX6’s ability to cause cancer and its oncogenic mechanism, we chose to focus on the HCC and CRC cancer types based on the findings of the aforementioned analysis of STX6’s role in pan-cancer. Here, STX6 is linked to hepatocellular carcinoma.